Contineum Therapeutics, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2023 | $-5.2M | $-5.3M | $52.0K | $494.0K |
| Jun 2023 | $40.7M | $40.6M | $31.0K | $489.0K |
| Sep 2023 | $-5.4M | $-5.4M | $22.0K | $477.0K |
| Dec 2023 | $-10.7M | $-11.0M | $309.0K | $759.0K |
| Mar 2024 | $-8.0M | $-8.1M | $147.0K | $768.0K |
| Jun 2024 | $-8.5M | $-8.6M | $119.0K | $1.5M |
| Sep 2024 | $-6.2M | $-6.3M | $82.0K | $2.3M |
| Dec 2024 | $-10.2M | $-10.4M | $166.0K | $2.3M |
| Mar 2025 | $-14.4M | $-14.5M | $47.0K | $2.6M |
| Jun 2025 | $-15.7M | $-15.7M | $44.0K | $2.4M |
| Sep 2025 | $-12.2M | $-12.3M | $98.0K | $2.6M |
| Dec 2025 | $-13.0M | $-13.1M | $42.0K | $2.5M |
| Mar 2026 | $-16.3M | $-16.6M | $312.0K | $3.8M |
| Jun 2026 | $-11.5M | $-11.5M | $6.0K | $3.8M |